醫學無國界，疾病無國界，醫學的跨國合作至關重要。作為兩個世界大國，中美兩國在應對全球日益增長的醫療需求與病人安全方面有很多共同的責任與義務進行深入的合作。

Medicine and disease know no borders; thus, it is crucial to have cross-border partnerships in healthcare. As world leaders, China and the United States have a mutual duty and responsibility to pursue collaborations that will fulfill the growing healthcare needs of our patients and ensure patient safety.

2017年9月7日，中國太平投資控股有限公司（以下簡稱“太平投資”）、美國加州大學舊金山分校醫學中心（以下簡稱“UCSF Health”）、以及美國彼愛醫療集團（以下簡稱“彼愛醫療”）三方在北京就國際醫療機構合作運營、國際醫院科室共建、醫務人員教學培訓、高凈值客戶海外就醫保障等方面的合作進行深入交流。

On September 7, 2017, Taiping Investment Holdings Company Ltd., the University of California, San Francisco (UCSF) Health, and Pier 88 Health, Inc. met in Beijing to discuss potential collaborations to develop centers of excellence, train medical staff and professionals, provide high-quality care for overseas patients, and develop other aspects of in-depth partnerships.

太平投資認為，保險與醫療具有天然的互動關系，與國際優質醫療機構合作，能夠有效促進保險與醫療協同發展。

Taiping Investment Holdings Company believes that insurance and medicine are interconnected, and that international medical institutions can effectively work together to foster the growth of insurance and healthcare in conjunction with one another.

UCSF Health表示，非常愿意與太平投資及彼愛醫療合作，共同推動全球醫療健康產業的發展，造福人類健康事業。

UCSF Health expressed its willingness to potentially collaborate with Taiping Investment Holdings Company and Pier 88 Health to jointly advance healthcare worldwide for the benefit of patient health and well-being.

彼愛醫療認為，三方的合作對于促進中美醫療交流合作，加速中國醫療系統和醫護人才與國際接軌具有積極作用。

Pier 88 Health believes that the collaboration between these three institutions will promote Sino-US medical exchanges and cooperation, accelerate developments for the Chinese medical system and its healthcare professionals, and improve international healthcare standards.

交流互動后，三方簽署了戰略合作協議，將在輔助生殖、骨科、腫瘤等專科醫院或綜合醫院的運營管理，高凈值人員海外體檢就醫，醫學大數據科學研究，臨床醫生、護士業務培訓，中美醫學學術交流等領域務實合作。

During the signing ceremony, all three parties signed a Letter of Intent outlining collaborations to assist with advisory services in the areas of reproductive health, orthopedics, cancer, and other specialties; international destination programs for patients needing complex care; medical research; professional training and education support for physicians and nurses; and academic medical exchanges between China and the US.

太平投資總經理吳松、副總經理王干，UCSF Health執行董事Harold Lilly、國際部主任Nida Shekhani，彼愛醫療首席執行官羅敏等出席簽約會議。

The signing ceremony was attended by Mr. Song Wu, President of Taiping Investment Holdings Company; Mr. Gan Wang, Vice President of Taiping Investment Holdings Company; Mr. Harold Lilly, Executive Director of UCSF Health, Ms. Nida Shekhani, Director of International Services of UCSF Health; and Ms. Min Luo, Chief Executive Officer of Pier 88 Health.

關于美國加州大學舊金山分校醫學中心

作為UCSF Health的基石，美國加州大學舊金山分校醫學中心在《美國新聞與世界報道》提供的“全美最佳醫院”排名中位居前五，同時，UCSF貝尼奧夫兒童醫院在九項兒童專科領域均躋身全美最佳。UCSF Health是美國加州大學舊金山分校的學術醫療中心，憑借其創新的療法、先進的技術、健康護理專業人員與科學家間的緊密合作以及富有同情心的病人護理團隊而備受認可，并因其生物醫學研究及卓越的研究生教育聞名于世。UCSF是美國國立衛生研究院研究基金資助的最大的公立接受者，已將其科研發現轉化為超過2000項醫學創新。UCSF全美卓越的項目包含癌癥、兒童健康、大腦和神經系統、器官移植、女性健康和行為健康。（具體請參閱www.ucsfhealth.org）

About UCSF Health

As the cornerstone of UCSF Health, UCSF Medical Center is ranked among the top five hospitals in the United States by U.S. News & World Report, and UCSF Benioff Children’s Hospitals rank among the nation’s best in nine pediatric specialties. Recognized for innovative treatments, advanced technology, collaboration among health care professionals and scientists, and a highly compassionate patient care team, UCSF Health serves as the academic medical center of University of California, San Francisco, which is world-renowned for its biomedical research and graduate-level education. UCSF is the largest public recipient of research funds from the National Institutes of Health and has translated its discoveries into more than 2,000 new medical innovations. UCSF’s nationally preeminent programs include cancer, children's health, the brain and nervous system, organ transplantation, women's health and behavioral health. Visit www.ucsfhealth.org.

關于美國彼愛醫療集團

美國彼愛醫療集團（Pier 88 Health, Inc.）是美國資深華人執業醫師、醫學院教授，醫院管理專家，醫療信息化專家等跨界人才共同創建的國際醫療平臺，總部位于加州硅谷。其使命包括為中國醫療機構和醫護專業人員提供世界一流的中美醫療交流和培訓項目，以及為中國患者提供精準前沿、流程簡易、價格公道的國際醫療服務。彼愛醫療致力于搭建中美醫療交流合作的高端精準平臺，加速中國醫療系統和醫護人才與國際接軌。彼愛醫療推動的合作內容涵蓋多個領域，包括醫院管理、臨床技術、臨床科研、醫師培訓、住院醫規培體系建立、國際會診、科室建設等；交流形式包括美國專家中國巡講研討、中國醫院管理層赴美考察培訓、中國醫護骨干赴美觀摩研修、中美醫療領袖峰會等。

About Pier 88 Health

Pier 88 Health is headquartered in Silicon Valley and was founded by a group of Chinese-American physicians, hospital management experts, and health IT professionals. Pier 88 Health’s mission is to provide world-class Chinese and American medical exchanges, offer Chinese hospitals and doctors professional education and training opportunities from the US, and to offer Chinese patients easy and affordable access to quality healthcare in the US. Pier 88 health is committed to building a Sino-US medical exchange and partnership to accelerate the Chinese medical system, as well as medical personnel and international standards. Pier 88 Health’s collaborations cover a diverse scope, including hospital management, technology, clinical research, physician training, international consultation, department development, and more. Medical exchanges encompass inviting US hospital physicians and industry experts to visit China’s top hospitals for knowledge sharing, inviting China’s hospital experts to the US for hospital management training, leadership summits, clinical observerships, and research

collaborations.